Search - tctmd.com

Displaying 601 - 620 of 1114

Sort: Relevancy | Date

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

April 03, 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame

News Daily News

Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame

Michael O'Riordan

March 27, 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

News Conference News ACC 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Yael L. Maxwell

March 22, 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

News Conference News ACC 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

Michael O'Riordan

March 20, 2019

‘Striking’ Improvements in Acute MI Care Over Past 20 Years, Report Shows

News Daily News

‘Striking’ Improvements in Acute MI Care Over Past 20 Years, Report Shows

Michael O'Riordan

March 19, 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

News Conference News ACC 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Michael O'Riordan

March 17, 2019

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

News Daily News

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Michael O'Riordan

March 15, 2019

Flu Vaccination Tied to Less MI in Hospitalized Patients

News Conference News

Flu Vaccination Tied to Less MI in Hospitalized Patients

March 13, 2019

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

News Daily News

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

Michael O'Riordan

March 08, 2019

Signal of Aortic Stenosis Risk With Celecoxib

News Daily News

Signal of Aortic Stenosis Risk With Celecoxib

Michael O'Riordan

March 05, 2019

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

News Daily News

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

February 27, 2019

New Equations Help ID Patients at Low Risk for Bleeding With Aspirin

News Daily News

New Equations Help ID Patients at Low Risk for Bleeding With Aspirin

Michael O'Riordan

February 26, 2019

Quality of CAD Care Varies by Type of Medicare Coverage

News Daily News

Quality of CAD Care Varies by Type of Medicare Coverage

February 20, 2019

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

News Daily News

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

February 15, 2019

Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable

News Daily News

Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable

February 12, 2019

Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke

News Conference News ISC 2019

Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke

February 12, 2019

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

News Daily News

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Michael O'Riordan

February 08, 2019

Intensive BP Lowering May Have Cognitive Benefits: SPRINT MIND

News Daily News

Intensive BP Lowering May Have Cognitive Benefits: SPRINT MIND

February 04, 2019

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.